Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study

Abstract Aims Hypoxia‐inducible factor‐prolyl hydroxylase (HIF‐PH) inhibitors have been developed for the treatment of renal anaemia; however, no study has evaluated the safety and efficacy of HIF‐PH inhibitors in patients with heart failure (HF). This study was designed to evaluate the safety and e...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Takashi Iso, Yuya Matsue, Akira Mizukami, Takashi Tokano, Kikuo Isoda, Satoru Suwa, Katsumi Miyauchi, Naotake Yanagisawa, Yasuo Okumura, Tohru Minamino
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Oxford University Press 2022-12-01
Schriftenreihe:	ESC Heart Failure
Schlagworte:	Anaemia Chronic kidney disease Daprodustat Heart failure HIF‐PH inhibitor Study protocol
Online-Zugang:	https://doi.org/10.1002/ehf2.14109
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!